Table 2.
Treatment trajectories in PCBaSe Traject
| Men with one treatment | n | (%) |
|---|---|---|
| CT AS | 6609 | (6.2) |
| CT WW | 8280 | (7.7) |
| CT UNS | 3667 | (3.4) |
| RP | 23 252 | (21.7) |
| CurRT | 14 525 | (13.6) |
| AA | 3534 | (3.3) |
| GnRH | 26 405 | (24.7) |
| Men with two treatments | ||
| CT AS → RP | 1584 | (1.5) |
| CT AS → RT | 824 | (0.8) |
| CT AS → AA | 271 | (0.3) |
| CT AS → GnRH | 186 | (0.2) |
| CT WW → AA | 1274 | (1.2) |
| CT WW → GnRH | 2402 | (2.2) |
| CT UNS → RP | 674 | (0.6) |
| CT UNS → RT | 523 | (0.5) |
| CT UNS → AA | 495 | (0.5) |
| CT UNS → GnRH | 746 | (0.7) |
| RP → RT | 3829 | (3.6) |
| RP → AA | 720 | (0.7) |
| RP → GnRH | 429 | (0.4) |
| CurRT → AA | 1065 | (1.0) |
| CurRT → GnRH | 1098 | (1.0) |
| AA → GnRH | 1812 | (1.7) |
| Men with three treatments | ||
| Starting in CT | 916 | (0.9) |
| Starting in RP | 1077 | (1.0) |
| Starting in RT | 443 | (0.4) |
| Men with four treatments | ||
| Starting in CT | 72 | (0.1) |
| Starting in RP | 204 | (0.2) |
| Men with five treatments | ||
| Starting in CT | 6 | (0.0) |
CT, conservative treatment; CT WW , watchful waiting; CT AS , active surveillance; CT UNS , unspecified conservative treatment; RP, radical prostatectomy; RT, curative radiotherapy; AA, anti-androgen monotherapy; GnRH, gonadotropin-releasing hormone agonist.